Seizure management in patients with gliomas

References

• Rudà R, Trevisan E, Soffietti R. Epilepsy and Brain Tumors. Curr Opin Oncol 2010;22(6):611-20
   PubMed Web of Science ®Google Scholar
• Vecht CJ, van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology 2006;67(12 Suppl 4):S10-13
   PubMedGoogle Scholar
• Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology 2002;59(Suppl 5):S21-6
   Google Scholar
• Olafsson E, Ludvigsson P, Gudmundsson G, et al. Incidence of unprovoked seizures ans epilepsy in Iceland and assessment of epilepsy syndrome classification: a prospective study. Lancet Neurol 2005;4:627-34
   PubMed Web of Science ®Google Scholar
• Whittle IR. The dilemma of low grade glioma. J Neurol Neurosurg Psychiatry 2004;75:ii31-6
   PubMedGoogle Scholar
• Batchelor T. Patient information: high-grade glioma in adults (beyond the basics). UpToDate; 2013
   Google Scholar
• Rudà R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 2012;14(Suppl 4):iv55-64
   PubMedGoogle Scholar
• Cashen A, Van Tine BA, Defer TM, Henderson KE. Brain tumors. In: The Washington Manual: hematology and oncology (Chapter 28). 3rd edition. Lippincott Williams and Wilkins; Philadelphia, PA, USA: 2012. p. 346-55
   Google Scholar
• Mangano FT, McBride AE, Schneider SJ. Oligodendroglioma. 2013. Available from: www.epilepsy.com/professionals
   Google Scholar
• Buckingham SC, Campbell SL, Haas BR, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011;17:1269-74
   PubMed Web of Science ®Google Scholar
• Shamji MF, Fric-Shamji EC, Benoit BG. Brain tumors and epilepsy: pathophysiology and peritumoral changes. Neurosurg Rev 2009;32:275-84
   PubMedGoogle Scholar
• DeLorenzo RJ, Hauser WA, Towne AR, et al. A Prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46(4):1029-35
   PubMed Web of Science ®Google Scholar
• Leppik IE. Pharmacokinetics; dynamics, & genomics of AEDs. Presented at: Cleveland clinic clinical epileptology review and update; 19–20 October 2012; Cleveland, OH, USA
   Google Scholar
• Edwards KR, Sackellares JC, Vuong A, et al. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2001;2(1):28-36
   PubMed Web of Science ®Google Scholar
• Tangamurnsuksan W, Sumkrua R, Lohitnavy M, Tassaneeyakul W. Relationship between the HLA-B* 1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta analysis. JAMA Dermatol 2013;149(9):1025-32
   PubMedGoogle Scholar
• Guerrini R, Rosati A, Giordano F, et al. The medical and surgical treatment of tumoral seizures: current anf future perspectives. Epilepsia 2013;54(Suppl 9):84-90
   PubMedGoogle Scholar
• Klein M, Engelberts N, van der Ploeg HM, et al. Epilepsy in Low-Grade Gliomas: the Impact on Cognitive Function and Quality of Life. Ann Neurol 2003;54:514-20
   PubMed Web of Science ®Google Scholar
• De Groot M, Douw L, Sizoo EM, et al. Levetiracetam improves verbal memory in high-grade glioma patients. Neuro Oncol 2013;15(2):216-23
   PubMed Web of Science ®Google Scholar
• Hakami T, Todaro M, Petrovski S, et al. Substitution monotherapy with levetiracetam vs older antiepileptic drugs: a randomized comparative trial. Arch Neurol 2012;69(12):1563-71
   PubMedGoogle Scholar
• Sizoo EM, Koekkoek J, Postma TJ, et al. Seizures in patients with high-grade gliomas: a serious challenge in the end-of-life phase. BMJ Support Palliat Care 2013; Epub ahead of print
   PubMedGoogle Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomized controlled trial. Lancet 2007;369(9566):1000-15
   PubMed Web of Science ®Google Scholar
• Crepeau AZ, Treiman PM. Levetiracetam: a comprehensive review. Expert Rev Neurother 2010;10(2):159-171.
   PubMed Web of Science ®Google Scholar
• Newton HB, Goldlust SA, Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 2006;78:1-99-102
   PubMedGoogle Scholar
• Rossetti AO, Jeckelmann S, Novy J, et al. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro Oncol 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Kerrigan S, Grant R. Antiepileptic drugs for treating seizures in adults with brain tumors. Cochrane Database Syst Rev 2011;10(8):CD00858625
   Google Scholar
• Maschio M, Dinapoli L, Zarabla A, et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 2008;86:61-70
   PubMed Web of Science ®Google Scholar
• Maschio M, Dinapoli L, Mingoia M, et al. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol 2011;258:2100-4
   PubMed Web of Science ®Google Scholar
• Striano S, Striano P, Boccella P, et al. Tiagabine in glial tumors. Epilepsy Res 2002;49:81-5
   PubMedGoogle Scholar
• Maschio M, Dinapoli L, Sperati F, et al. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neurooncol 2012;106(3):651-6
   PubMed Web of Science ®Google Scholar
• van Breemen MS, Rijsman RM, Taphoorn MJ, et al. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 2009;256(9):1519-26
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Oncol 2010;23(6):603-9
   Google Scholar
• Honarmand A, Safavi M, Zare M. Gabapentin: an update of its pharmacological properties and therapeutic use in epilepsy. J Res Med Sci 2011;16(8):1062-9
   PubMed Web of Science ®Google Scholar
• Crepeau AZ, Treiman PM. Levetiracetam: a comprehensive review. Expert Rev Neurother 2010;10(2):159-71
   PubMed Web of Science ®Google Scholar
• Saria MG, Corle C, Hu J, et al. Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 2013;118(6):1183-7
   PubMed Web of Science ®Google Scholar
• William O, Tatum IV. Antiepileptic drugs: adverse effects and drug interactions. Continuum (Minneap Minn) 2010;16:3-136-58
   Google Scholar
• Noe KH, Pack AM. Women's issues and epilepsy. Continuum (Minneap Minn) 2010;16(3):159-78
   PubMedGoogle Scholar
• Isojärvi J, Löfgren E, Juntunen K, et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004;62(2):247-53
   PubMed Web of Science ®Google Scholar
• Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004;5(Suppl 2):s41-7
   PubMedGoogle Scholar
• Lazzari AA, Dussault PM, Thakore-James M, et al. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy – antiepileptic drug and osteoporosis prevention trial. Epilepsia 2013;54(11):1997-2004
   PubMed Web of Science ®Google Scholar
• Kern K, Schebesch KM, Schlaier J, et al. Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy. J Clin Neurosci 2012;19(1):99-100
   PubMed Web of Science ®Google Scholar
• Fuller KL, Wang YY, Cook MJ, et al. Tolerability, safety and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 2013;54(1):45-57
   PubMedGoogle Scholar
• Wu AS, Trinh VT, Suki D, et al. A prospective randomized trial of perioperative seizure prophylaxis in patient with intraparenchymal brain tumors. J Neurosurg 2013;118(4):873-83
   PubMedGoogle Scholar
• Garbossa D, Panciani PP, Angeleri R, et al. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Neurol India 2013;61(2):131-7
   PubMedGoogle Scholar
• Pulman J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2013;2:CD007286
   Google Scholar
• Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameters: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 2000;54:1886-93
   PubMed Web of Science ®Google Scholar
• Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 2005;293(5):557-64
   PubMed Web of Science ®Google Scholar
• Rheims S, Ducray F, Ryvlin P. Choosing the tumoral epilepsy surgery candidate. Epilepsia 2013;54(Suppl 9):91-6
   PubMedGoogle Scholar
• Bello L, Fava E, Carrabba G, et al. Present day's standards in microsurgery of low-grade gliomas. Adv Tech Stand Neurosurg 2010;35:113-57
   PubMedGoogle Scholar
• Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 1997;41:2-378-86
   Google Scholar
• Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008;108:2-227-35
   Google Scholar
• Luyken C, Blümcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003;44:822-30
   PubMed Web of Science ®Google Scholar
• Englot DJ, Berger MS, Barbaro NM, et al. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 2011;115:240-4
   PubMedGoogle Scholar
• Smith VL. Resection strategies in tumoral epilepsy: is a lesionectomy enough ? Epilepsia 2013;54(Suppl 9):72-8
   Google Scholar
• Shinoda J, Yokoyama K, Miwa K, et al. Epilepsy surgery of dysembryoplastic neuroepithelial tumors using advanced multitechnologies with combined neuroimaging and electrophysiological examinations. Epilepsy and Behavior Case Reports 2013;1:97-105
   PubMedGoogle Scholar
• Englot DJ, Han SJ, Berger MS, et al. Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery 2012;70(4):921-8
   PubMed Web of Science ®Google Scholar
• Hu WH, Ge M, Zhang K, et al. Seizure outcome with surgical management of epileptogenic ganglioglioma: a study of 55 patients. Acta Neurochir (Wien) 2012;154(5):855-61
   PubMedGoogle Scholar
• Sweet JA, Hdeib AM, Sloan A, Miller JP. Depths and grids in brain tumors: implantation strategies, techniques and complications. Epilepsia 2013;54(Suppl 9):66-71
   PubMedGoogle Scholar
• Warnke PC, Berlis A, Weyerbrock A, Ostertag CB. Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radio surgery on low grade gliomas. Acta Neurochir 1997;68:90-2
   Google Scholar
• van den Bent MJ, Afra D, de Witte O, et al. EORTC radiotherapy and brain tumor groups and the UK Medical Research Council. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomized trial. Lancet 2005;366:985-90
   PubMed Web of Science ®Google Scholar
• Schröttner O, Unger F, Eder HG, et al. Gamma-Knife radiosurgery of mesiotemporal tumor epilepsy observations and long-term results. Acta Neurochir (Wien) 2002;84:49-55
   Google Scholar
• Rudà R, Magliola U, Bertero L, et al. Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol 2013;15(12):1739-49
   PubMed Web of Science ®Google Scholar
• Brada M, Viviers L, Asbon C, et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 2003;14:1715-12
   PubMed Web of Science ®Google Scholar
• Pace A, Vidiri A, Galie E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 2003;14:1722-6
   PubMed Web of Science ®Google Scholar
• Sherman JH, Moldovan K, Yeoh HK, et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 2011;114(6):1617-21
   PubMed Web of Science ®Google Scholar
• Rudà R, Bertero L, Trevisan E, et al. Phase II trial of dose-dense temozolomide as initial treatment for progressive low-grade oligodendroglial tumors: a multicentric study of the Italian Association of Neuro-Oncology (AINO). Abstract. J Clin Oncol 2012;30:2037
   Google Scholar
• Rogers LR. Chemotherapy and immunotherapy of brain tumors: what the epileptologist must know. Epilepsia 2013;54(Suppl 9):105-8
   PubMedGoogle Scholar
• Grossman SA, Carson KA, Batchelor TT, et al. The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochloride. Clin Cancer Res 2006;12:5174-81
   PubMedGoogle Scholar
• Lehmann DF, Hurteau TE, Newman N, Coyle TE. Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors. Clin Pharmacol Ther 1997;62:225-9
   PubMed Web of Science ®Google Scholar
• Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen ? Epilepsia 2013;54(Suppl 9):30-4
   PubMedGoogle Scholar
• van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumors: epidemiology, mechanisms and management. Lancet 2007;6:421-30
   Google Scholar
• Calatozzolo C, Pollo B, Botturi A, et al. Multidrug resistance proteins expression in glioma patients with epilepsy. J Neurooncol 2012;110(1):129-35
   PubMed Web of Science ®Google Scholar
• Das RR, Artsy E, Hurwitz S, et al. Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol 2012;107(3):656-570
   Google Scholar
• Weller M, Gorlia T, Cairncross JG, et al. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 2011;77(12):1156-64
   PubMed Web of Science ®Google Scholar
• Ryu CH, Yoon WS, Park KY, et al. Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells. J Biomed Biotechnol 2012;2012:987495
   PubMedGoogle Scholar
• Nakada M, Furuta T, Hayashi Y, et al. The startegy for enhancing temozolomide against malignant glioma. Front Oncol 2012;2:98
   PubMedGoogle Scholar